Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neuroscience and Biobehavioral Reviews|May 6, 2024
Exploring causal mechanisms of psychosis riskDominic Oliver, Edward Chesney, Alexis E Cullen, et al.
NPJ Schizophrenia|August 3, 2019
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamateKate Merritt, Rocio Perez-Iglesias, Kyra-Verena Sendt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Molecular Psychiatry|October 31, 2023
The impact of cumulative obstetric complications and childhood trauma on brain volume in young people with psychotic experiencesKate Merritt, Pedro Luque Laguna, Arjun Sethi, et al.
Schizophrenia (Heidelberg, Germany)|April 17, 2025
PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sampleStefania Tognin, Sandra Vieira, Dominic Oliver, et al.
Molecular Psychiatry|September 12, 2024
Molecular and micro-architectural mapping of gray matter alterations in psychosisNatalia García-San-Martín, Richard A I Bethlehem, Agoston Mihalik, et al.
Schizophrenia Bulletin|October 15, 2020
Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE StudyPaola Dazzan, Andrew J Lawrence, Antje A T S Reinders, et al.
JAMA Psychiatry|June 24, 2026
Neurometabolites and Antipsychotic Response in Psychosis: A Mega-AnalysisBridget King, Kirsten Borup Bojesen, Charlotte Crisp, et al.
Pageof 3